TY - JOUR
T1 - Persistent polyclonal B-cell lymphocytosis: Study of 35 cases
AU - Florensa, Lourdes
AU - Navarro, José Tomás
AU - Pérez Vila, María Encarnación
AU - Domingo, Alicia
AU - De La Banda, Esmeralda
AU - Rozman, Maria
AU - Camós, Mireia
AU - Millá, Fuensanta
AU - Perea, Granada
AU - Alonso, Esther
AU - Ayats, Ramon
AU - Aventín, Ana
AU - Cabezudo, Elena
AU - Espinet, Blanca
AU - Merino, Ana
AU - Romero, Pilar
AU - Sánchez, Carmen
AU - Tuset, Esperanza
AU - Solé, Francesc
AU - Feliu, Evarist
AU - Fernández, Cristalina
AU - Gallart, Miquel
AU - Vallespí, Teresa
AU - Woessner, Soledad
PY - 2011/5/14
Y1 - 2011/5/14
N2 - Background and objectives: Persistent polyclonal B-cell lymphocytosis (PPBL) is a rare entity, presenting especially in adult smoker women. It is characterized by an increase of serum IgM, DR7-HLA haplotype, cytogenetic abnormalities and multiple IgH/BCL-2 rearrangements. To date, it has not been elucidated whether this is a benign or premalignant disorder. We analyzed the PPBL characteristics with especial attention to its evolution. Patients and methods: Thirty-five PPBL patients from 5 hospitals in Catalonia were retrospectively analyzed. A simultaneous morphologic review of the blood smears was performed by members of the GCCH in a 16 multiple-observer optic microscope. Clinical and biological data were also analyzed. Results: PPBL presents in the majority of cases with persistent polyclonal B-cell lymphocytosis and affects primarily smoker women. The morphologic hallmark, in absence of viral infections, is the presence of activated lymphocytes with bilobulated and/or cleaved nuclei, and nuclear pockets in the ultrastructural study. Increased serum IgM, HLA-DR7 haplotype, chromosomal abnormalities such as i(3)(q10) and multiple IgH/BCL-2 rearrangements were detected. Thirty-four out of 35 patients are alive after a median follow up of 70.7 months. One patient died because of lung adenocarcinoma and another developed a follicular lymphoma without relation to PPBL. Conclusions: PPBL has an asymptomatic and stable evolution, although it frequently presents genetic abnormalities. It remains unknown whether it is a premalignant entity, similar to monoclonal gammopathies of unknown significance. Hence, accurate cytologic diagnosis and follow-up are essential. © 2010 Elsevier España.
AB - Background and objectives: Persistent polyclonal B-cell lymphocytosis (PPBL) is a rare entity, presenting especially in adult smoker women. It is characterized by an increase of serum IgM, DR7-HLA haplotype, cytogenetic abnormalities and multiple IgH/BCL-2 rearrangements. To date, it has not been elucidated whether this is a benign or premalignant disorder. We analyzed the PPBL characteristics with especial attention to its evolution. Patients and methods: Thirty-five PPBL patients from 5 hospitals in Catalonia were retrospectively analyzed. A simultaneous morphologic review of the blood smears was performed by members of the GCCH in a 16 multiple-observer optic microscope. Clinical and biological data were also analyzed. Results: PPBL presents in the majority of cases with persistent polyclonal B-cell lymphocytosis and affects primarily smoker women. The morphologic hallmark, in absence of viral infections, is the presence of activated lymphocytes with bilobulated and/or cleaved nuclei, and nuclear pockets in the ultrastructural study. Increased serum IgM, HLA-DR7 haplotype, chromosomal abnormalities such as i(3)(q10) and multiple IgH/BCL-2 rearrangements were detected. Thirty-four out of 35 patients are alive after a median follow up of 70.7 months. One patient died because of lung adenocarcinoma and another developed a follicular lymphoma without relation to PPBL. Conclusions: PPBL has an asymptomatic and stable evolution, although it frequently presents genetic abnormalities. It remains unknown whether it is a premalignant entity, similar to monoclonal gammopathies of unknown significance. Hence, accurate cytologic diagnosis and follow-up are essential. © 2010 Elsevier España.
KW - Bilobulated lymphocyte
KW - HLA-DR7
KW - i(3)(q10)
KW - Polyclonal B-lymphocytosis
KW - Smoker
U2 - 10.1016/j.medcli.2010.09.048
DO - 10.1016/j.medcli.2010.09.048
M3 - Article
VL - 136
SP - 565
EP - 573
IS - 13
ER -